Xenetic Biosciences, Inc. (XBIO)

NASDAQ: XBIO · Real-Time Price · USD

2.766

+0.346 (14.30%)

At close: Jan 22, 2026, 4:00 PM EST

2.810

+0.044 (1.59%)

Pre-market: Jan 23, 2026, 4:00 AM EST

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
Cell-based Therapeutics	2.54M	Log In	Log In	Log In	Log In	Upgrade
Cell-based Therapeutics Growth	48.80%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2014 - 2018
Period Ending	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2014 - 2018
United States	2.54M	Log In	Log In	Log In	Log In	Upgrade
United States Growth	48.80%	Log In	Log In	Log In	Log In	Upgrade